The ECCO 2018 European Cancer Summit, was held on 7-9 September 2018 in Vienna, Austria bringing together worldwide leaders from the cancer healthcare, patient advocacy and stakeholder communities in a unique multidisciplinary forum.
HARMONY Partners Jan Geissler, LeukaNet and Denis Lacombe, EORTC, participated in the debate session: Big Data – who’s in charge?
About the ECCO2018 Big Data session: Stakeholders recognise the benefits big data can bring to research and improvement of care and treatment for cancer. However, its full realisation is unlikely to occur without leadership, responsibility, strategy, direction, and implementation. What aspects of leadership and responsibility appear to be presently missing in terms of bringing big data opportunities to fruition, to whom should these leadership roles be assigned, and where does accountability reside? Implicit within this discussion is considered reflection on whether the realisation of a big data-driven future in research requires the strong hand of government-led efforts, or whether responsibilities are of a more shared and distributed nature?
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
